Skip to Main Content

Author Details

Jun Wei
The University of Texas MD Anderson Cancer Center
2004
51
32
PMIDPaper TitleJournal TitlePublished Year
35914692Acoustically accelerated neural differentiation of human embryonic stem cells.Acta Biomater2022
35433114Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system.Oncoimmunology2022
35575067A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.CNS Oncol2022
34138753Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.J Clin Invest2021
34532286Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.Front Oncol2021
34031054Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.Clin Cancer Res2021
32567735Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.EMBO J2020
31679017Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.Neuro Oncol2020
33348707MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.Cancers (Basel)2020
32605912Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.Clin Cancer Res2020
32721947Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.JCI Insight2020
32554515Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.Clin Cancer Res2020
30307407Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.J Clin Invest2019
28965162Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.J Neurooncol2018
29869738Rethinking medulloblastoma from a targeted therapeutics perspective.J Neurooncol2018
29632728Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.Oncoimmunology2018
27765835Immune modulatory nanoparticle therapeutics for intracerebral glioma.Neuro Oncol2017
26973881Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.JCI Insight2016
26658052MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.Neuro Oncol2016
26323609PD-L1 expression and prognostic impact in glioblastoma.Neuro Oncol2016
27376157MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.J Gene Ther2016
25619840C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy.Oncogene2015
27467917Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.Oncoimmunology2015
24974128Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.J Natl Cancer Inst2014
25465288Therapeutic targets in subependymoma.J Neuroimmunol2014
23636127miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.Cancer Res2013
24409449Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.Cancer Immunol Res2013
24083077MicroRNAs as novel immunotherapeutics.Oncoimmunology2013
23983766The controversial role of microglia in malignant gliomas.Clin Dev Immunol2013
21792892The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.Int J Cancer2012
23013619Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.Oncotarget2012
22753228Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Neuro Oncol2012
21490182Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.Clin Cancer Res2011
22468222miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.Clin Investig (Lond)2011
21283755Hypoxia potentiates glioma-mediated immunosuppression.PLoS One2011
20053772Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.Mol Cancer Ther2010
20737294Immune therapeutic targeting of glioma cancer stem cells.Target Oncol2010
20921210Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.Clin Cancer Res2010
20667896Glioma cancer stem cells induce immunosuppressive macrophages/microglia.Neuro Oncol2010
20388845Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.Clin Cancer Res2010
19944972The role of tregs in glioma-mediated immunosuppression: potential target for intervention.Neurosurg Clin N Am2010
20068105Glioma-associated cancer-initiating cells induce immunosuppression.Clin Cancer Res2010
18594817Topotecan enhances immune clearance of gliomas.Cancer Immunol Immunother2009
20214040The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.Clin Neurosurg2009
19900287yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.J Transl Med2009
19002459A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.Cancer Immunol Immunother2009
18794085A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.Clin Cancer Res2008
19088040The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.Clin Cancer Res2008
17978190Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.Proc Natl Acad Sci U S A2007
15712204Novel spatiotemporal patterns of epithelial tumor invasion in Drosophila discs large egg chambers.Dev Dyn2005
  • 1 - 50 of 51

Recommended Authors

Princess Margaret Cancer Centre
Career Start Year 2016
Number of shared co-authors 7
McMaster University
Career Start Year 2015
Number of shared co-authors 0
McMaster University
Career Start Year 2015
Number of shared co-authors 0
Columbia University
Career Start Year 2014
Number of shared co-authors 2
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 1
Department of Research and Development, Shanghai United Imaging Intelligence Co.
Career Start Year 2010
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Westlake University
Career Start Year 2009
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
University of Lausanne
Career Start Year 2008
Number of shared co-authors 0
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 2
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 4
Johannes Kepler University
Career Start Year 2001
Number of shared co-authors 0
Lerner Research Institute, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 6
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 5
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 10
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 8
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 15
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 4
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 2
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 4
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 10
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 1
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 10
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 1

Collaborators

Northwestern University Feinberg School of Medicine
Co-authored papers 46
The University of Texas MD Anderson Cancer Center
Co-authored papers 28
MD Anderson Cancer Center
Co-authored papers 23
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 17
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
South China University of Technology
Co-authored papers 14
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 13
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 6
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Co-authored papers 5
Xuanwu Hospital, Capital Medical University
Co-authored papers 4
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers 3
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers 3
NYU Grossman School of Medicine
Co-authored papers 3
National Cancer Institute
Co-authored papers 2
The MD Anderson Cancer Center
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
School of Medicine and Pharmacy, Ocean University of China
Co-authored papers 1
CIMA-Universidad de Navarra
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
Hopital Universitaire Necker-Enfants Malades
Co-authored papers 1
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1